A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants

Clinical trial NCT02271425 · COMPLETED

Trial details

NCT number: NCT02271425
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2014-10-01
Primary completion: 2014-11-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.